The bullous pemphigoid market comprises autoimmune skin condition characterized by formation of fluid-filled blisters on the skin. Bullous pemphigoid treatment involves medication like corticosteroids, immunosuppressants and biologics to reduce symptoms of itching and blistering.
The Bullous Pemphigoid Market is estimated to be valued at US$ 1.4 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the bullous pemphigoid market are Glaxo Smith Kline, Novartis, Pfizer, Astra Zeneca, and Roche. GlaxoSmithKline offers several treatment options for bullous pemphigoid like predisone and doxycycline. Key players are involved in developing novel therapies for effective bullous pemphigoid treatment.
The growing demand in bullous pemphigoid market can be attributed to increasing aging population prone to acquire autoimmune diseases and rising awareness about early diagnosis. As per estimates, nearly 1 to 3 individuals out of every 1 million gets diagnosed with bullous pemphigoid annually.
Companies are expanding their bullous pemphigoid treatment offerings globally with focus on emerging markets in Asia, South America, Middle East and Africa. Favorable reimbursements for bullous pemphigoid medications across various countries is supporting global expansion of bullous pemphigoid market.
Market Key Trends
Increasing research activities for developing monoclonal antibodies and targeted therapies hold potential to drive future bullous pemphigoid treatment trends. Several biotech companies are exploring ability of antibodies to selectively target specific antigens related to bullous pemphigoid pathogenesis. This could help offer safer and more effective treatment options compared to generic medications having several side effects.
Porter’s Analysis
Threat of new entrants: Low barriers in terms of investment and technology required however brand loyalty and established suppliers make market entry difficult.
Bargaining power of buyers: Buyers have moderate bargaining power as therapeutics choices are available but high treatment costs.
Bargaining power of suppliers: Suppliers like drug manufacturers have high bargaining power being limited in number along with intellectual property on drugs.
Threat of new substitutes: Limited threat as no major substitute treatments exist for bullous pemphigoid currently.
Competitive rivalry: High competition exists among major pharmaceutical companies.
Geographical Regions
North America accounts for the largest share in bullous pemphigoid therapeutics market in terms of value owing to growing aging population, higher treatment rates and healthcare spending.
Asia Pacific region is expected to witness fastest growth over forecast period attributed to rising healthcare investments, growing medical tourism and increasing bullous pemphigoid cases associated with aging population in countries like China and India.
What Are The Key Data Covered In This Bullous Pemphigoid Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Bullous Pemphigoid Market’s growth between 2024 and 2031.
:- Accurate calculation of the size of the Bullous Pemphigoid Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Bullous Pemphigoid Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Bullous Pemphigoid Market vendors
FAQ’s
Q.1 What are the main factors influencing the Bullous Pemphigoid Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Bullous Pemphigoid Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Bullous Pemphigoid Market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
About Author - Money Singh
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc. LinkedIn Profile